NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 264 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $351,000 | +25.8% | 18,000 | +15.5% | 0.01% | 0.0% |
| Q4 2020 | $279,000 | +16.2% | 15,578 | +9.8% | 0.01% | -25.0% |
| Q3 2020 | $240,000 | -52.3% | 14,194 | -36.7% | 0.01% | -55.6% |
| Q2 2020 | $503,000 | -14.2% | 22,436 | +32.7% | 0.02% | -5.3% |
| Q2 2019 | $586,000 | -18.9% | 16,911 | -21.4% | 0.02% | -45.7% |
| Q1 2019 | $723,000 | -6.0% | 21,507 | -8.1% | 0.04% | -2.8% |
| Q4 2018 | $769,000 | -52.8% | 23,407 | -12.4% | 0.04% | -41.0% |
| Q3 2018 | $1,630,000 | -75.3% | 26,732 | +34.4% | 0.06% | -87.2% |
| Q2 2018 | $6,601,000 | – | 19,892 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |